{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:15:07Z","timestamp":1783318507793,"version":"3.54.6"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate spontaneous thyroid-stimulating hormone (TSH) normalization (TSH\u2009\u2264\u20092\u2005\u03bcIU\/mL) and its predictors in patients with low-risk papillary thyroid microcarcinoma (PTMC) who underwent unilateral lobectomy without pharmacological intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study enrolled 411 low-risk PTMC patients who underwent unilateral lobectomy. Clinical, pathological, and preoperative biochemical data were collected, including thyroid function tests (fT3, fT4, TSH), thyroglobulin (Tg), and thyroid autoantibodies (TPO-Ab, Tg-Ab). TSH levels were monitored at 0.5, 1.5, 6, and 12 months postoperatively. Binary logistic regression and ROC curve analyses were used to identify preoperative predictors of spontaneous TSH normalization at 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The rate of spontaneous TSH normalization progressively declined: 32.4% at 0.5 months, 20.2% at 1.5 months, 14.8% at 6 months, and 12.4% at 12 months. In contrast, TSH target achievement with thyroid hormone therapy increased over time, reaching 100% at 12 months. Patients with spontaneous normalization at 12 months were younger, had higher preoperative fT3, and lower preoperative TSH (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Preoperative TSH was an independent predictor, with an optimal cutoff of \u2264\u20091.7\u2005\u03bcIU\/mL for predicting TSH\u2009\u2264\u20092\u2005\u03bcIU\/mL at 12 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Approximately 12.4% of low-risk PTMC patients achieved spontaneous TSH normalization within one year after lobectomy, obviating hormone replacement. A preoperative TSH\u2009\u2264\u20091.7\u2005\u03bcIU\/mL serves as a useful predictor, supporting individualized management by deferring or avoiding levothyroxine supplementation in eligible patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1821314","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:36:58Z","timestamp":1783316218000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and predictors of spontaneous thyroid-stimulating hormone normalization after lobectomy for low-risk papillary thyroid microcarcinoma: evidence from contemporary clinical practice"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhou Ting","family":"Li","sequence":"first","affiliation":[{"name":"Head and Neck Surgery, The Fifth Affiliated Hospital of Wenzhou Medical University","place":["Lishui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Ultrasonic Medicine, The Fifth Affiliated Hospital of Wenzhou Medical University","place":["Lishui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu Long","family":"Du","sequence":"additional","affiliation":[{"name":"Head and Neck Surgery, The Fifth Affiliated Hospital of Wenzhou Medical University","place":["Lishui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Lishui Center for Disease Control and Prevention","place":["Lishui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Jie","family":"Zhao","sequence":"additional","affiliation":[{"name":"Head and Neck Surgery, The Fifth Affiliated Hospital of Wenzhou Medical University","place":["Lishui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Head and Neck Surgery, The Fifth Affiliated Hospital of Wenzhou Medical University","place":["Lishui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian Song","family":"Ji","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Imaging and Interventional Medicine, Key Laboratory of Precision Medicine of Lishui City, The Fifth Affiliated Hospital of Wenzhou Medical University","place":["Lishui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Head and Neck Surgery, The Fifth Affiliated Hospital of Wenzhou Medical University","place":["Lishui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/s0140-6736(23)00020-x","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"B3","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/thy.2023.0173","article-title":"Regulation of thyroid hormone levels by hypothalamic thyrotropin-releasing hormone neurons","volume":"33","author":"Costa","year":"2023","journal-title":"Thyroid"},{"key":"B4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/thy.2009.0311","article-title":"Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer","volume":"20","author":"Biondi","year":"2010","journal-title":"Thyroid"},{"key":"B5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12020-023-03548-8","article-title":"Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy","volume":"83","author":"Benjamin","year":"2023","journal-title":"Endocrine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/hed.24926","article-title":"Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: the role for a combined T3\/T4 approach","volume":"39","author":"Mark F","year":"2017","journal-title":"Head Neck"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B8","first-page":"181","article-title":"Diagnosis and treatment guidelines for thyroid nodules and differentiated thyroid cancer (second edition)","volume":"39","year":"2023"},{"key":"B9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/03008916211025098","article-title":"Systematic review of health-related quality of life following thyroid cancer","volume":"108","author":"Walshaw","year":"2022","journal-title":"Tumori"},{"key":"B10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1089\/thy.2023.0691","article-title":"Five-year follow-up of health-related quality of life in differentiated thyroid cancer patients treated with total thyroidectomy and radioiodine in Sweden: a nationwide prospective cohort study","volume":"34","author":"Winter","year":"2024","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1089\/thy.2021.0033","article-title":"Thyrotropin suppression for papillary thyroid cancer: a physician survey study","volume":"31","author":"Papaleontiou","year":"2021","journal-title":"Thyroid"},{"key":"B12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.eprac.2021.01.004","article-title":"Frequency of thyroid hormone replacement after lobectomy for differentiated thyroid cancer","volume":"27","author":"Schumm","year":"2021","journal-title":"Endocr Pract"},{"key":"B13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/cen.14580","article-title":"Is thyroid hormone supplementation avoidable for patients with low-risk papillary thyroid cancer after thyroid lobectomy? A two-center observational study","volume":"96","author":"Xiao","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12893-024-02426-y","article-title":"Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/jcm8081106","article-title":"Association between thyroid-stimulating hormone level after total thyroidectomy and hypercholesterolemia in female patients with differentiated thyroid cancer: a retrospective study","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12020-021-02971-z","article-title":"Risk factors for thyroid hormone replacement therapy after hemithyroidectomy and development of a predictive nomogram","volume":"76","author":"Cao","year":"2022","journal-title":"Endocrine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1210\/jc.2016-3597","article-title":"Clinical features of early and late postoperative hypothyroidism after lobectomy","volume":"102","author":"Park","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/jcm8091279","article-title":"Optimal thyrotropin suppression therapy in low-risk thyroid cancer patients after lobectomy","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fendo.2020.00520","article-title":"Thyroid hormone supplementation therapy for differentiated thyroid cancer after lobectomy: 5 years of follow-up","volume":"11","author":"Kim","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3240727","DOI":"10.1155\/2016\/3240727","article-title":"The effect of levothyroxine discontinuation timing on postoperative hypothyroidism after hemithyroidectomy for papillary thyroid microcarcinoma","volume":"2016","author":"Ha","year":"2016","journal-title":"Int J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.amjsurg.2020.07.001","article-title":"Postoperative thyroid hormone supplementation rates following thyroid lobectomy","volume":"221","author":"Wilson","year":"2021","journal-title":"Am J Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12020-021-02911-x","article-title":"Thyroid stimulating hormone suppression and recurrence after thyroid lobectomy for papillary thyroid carcinoma","volume":"75","author":"Bae","year":"2022","journal-title":"Endocrine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jss.2014.07.003","article-title":"Prediction of thyroid hormone supplementation after thyroid lobectomy","volume":"193","author":"Lee","year":"2015","journal-title":"J Surg Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12020-021-02690-5","article-title":"Association between preoperative serum TSH and tumor status in patients with papillary thyroid microcarcinoma","volume":"73","author":"Mao","year":"2021","journal-title":"Endocrine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1305386","DOI":"10.3389\/fendo.2023.1305386","article-title":"Correlation between systemic inflammatory response index and thyroid function: 2009-2012 NHANES results","volume":"14","author":"Zhai","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1590\/1806-9282.20220255","article-title":"Repercussion of thyroid dysfunctions in thyroidology on the reproductive system: conditio sine qua non?","volume":"68","author":"Sengul","year":"2022","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1089\/thy.2017.0177","article-title":"Thyrotropin suppressive therapy for low-risk small thyroid cancer: a propensity score-matched cohort study","volume":"27","author":"Park","year":"2017","journal-title":"Thyroid"},{"key":"B28","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3803\/EnM.2020.943","article-title":"A multicenter, randomized, controlled trial for assessing the usefulness of suppressing thyroid stimulating hormone target levels after thyroid lobectomy in low to intermediate risk thyroid cancer patients (MASTER): a study protocol","volume":"36","author":"Lee","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1001\/jama.2023.19052","article-title":"Hyperthyroidism: a review","volume":"330","author":"Lee","year":"2023","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"102912","DOI":"10.1016\/j.eclinm.2024.102912","article-title":"Thyroid-stimulating hormone suppression in low-risk papillary thyroid cancer: a large-scale retrospective analysis of real-world data","volume":"77","author":"Shi","year":"2024","journal-title":"eClinicalMed"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1210\/jc.2010-0161","article-title":"Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial","volume":"95","author":"Sugitani","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1507\/endocrj.EJ24-0644","article-title":"The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery","volume":"72","author":"Sugitani","year":"2025","journal-title":"Endocr J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e230459","DOI":"10.1148\/radiol.230459","article-title":"Microwave ablation versus surgical resection for US-detected multifocal T1N0M0 papillary thyroid carcinoma: a 10-center study","volume":"311","author":"Zhao","year":"2024","journal-title":"Radiology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1089\/thy.2018.0263","article-title":"Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea","volume":"28","author":"Oh","year":"2018","journal-title":"Thyroid"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1821314\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:36:59Z","timestamp":1783316219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1821314\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":34,"alternative-id":["10.3389\/fsurg.2026.1821314"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1821314","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"1821314"}}